A Study of JNJ-55308942 in the Treatment of Bipolar Depression
Status:
Not yet recruiting
Trial end date:
2024-05-22
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy of JNJ-55308942 compared to placebo on
symptoms of depression in participants with bipolar disorder (BD) in a major depressive
episode (MDE) at Week 6.